Treatment of challenging behaviour with medication; is there another way?

Integration of medical, psychiatric and behavioural care for the substantiated and appropriate use of psychotropic drugs in individuals with an intellectual disability and challenging behaviour

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON23433

Enrollment

Registered

2019-07-12

Start date

2020-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental health problems

Interventions

Integrative care provided by a specialist mental health care team

Eligibility

Inclusion criteria

Inclusion criteria: - Person with a moderate to profound intellectual disability (level of cognitive development 12 years - Off-label psychotropic drug use for more than one year - Informed consent (IC) signed by participant and/or participant representative (depending on the competence of the participant)

Exclusion criteria

Exclusion criteria: - One of the following DSM diagnoses: - Dementia - Chronic psychotic disorder - Schizoaffective disorder - Bipolar disorder type I - Significant life event in the past six months

Design outcomes

Primary

Measure	Time frame
Aberrant Behavior Checklist	—

Secondary

Measure	Time frame
Behavior Problems Inventory, Quantity and quality of off-label psychotropic drug prescription, Medical diagnoses, Restrictive measures, Implemented interventions, Type, dosage and frequency of psychotropic drugs, The number and nature of side-effects of psychotropic drug use, Baselin measures: Minimal Data Set (MDS), Personal Outcome Scale (POS), Checklist Life Events (CLE), Psychiatric Assessment Schedule for Adults with a Developmental Disability Checklist (PAS-ADD Checklist), Vragenlijst over Ontwikkeling en Gedrag van kinderen (VOG)	—

Measure

Time frame

Behavior Problems Inventory, Quantity and quality of off-label psychotropic drug prescription, Medical diagnoses, Restrictive measures, Implemented interventions, Type, dosage and frequency of psychotropic drugs, The number and nature of side-effects of psychotropic drug use, Baselin measures: Minimal Data Set (MDS), Personal Outcome Scale (POS), Checklist Life Events (CLE), Psychiatric Assessment Schedule for Adults with a Developmental Disability Checklist (PAS-ADD Checklist), Vragenlijst over Ontwikkeling en Gedrag van kinderen (VOG)

—

Contacts

Public ContactGerda de Kuijper

GGZ Drenthe

Gerda.de.Kuijper@ggzdrenthe.nl0631623826

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)